Literature DB >> 10635003

Role of pyruvate dehydrogenase in lactate production in exercising human skeletal muscle.

G J Heigenhauser1, M L Parolin.   

Abstract

The mechanisms responsible for lactate production with increased intensity of muscle contraction are controversial. Some investigators suggest that the mitochondria are O2-limited, whereas others suggest that lactate production occurs when O2 to the mitochondria is adequate and that the increased lactate production is due to a "mass-action effect" when pyruvate production exceeds the rate of pyruvate oxidation. Pyruvate dehydrogenase is a rate-limiting enzyme for pyruvate entry into the tricarboxylic acid cycle; its catalytic activity influences both pyruvate oxidation and lactate production. Since lactate dehydrogenase is an equilibrium enzyme, increased lactate production will be due to a mass-action effect exerted by increases in pyruvate concentrations. Because the equilibrium constant of the lactate dehydrogenase reaction markedly favors lactate over pyruvate, small increases in pyruvate concentration will result in large increases in lactate concentration. At higher exercise intensities, which are more reliant on glycogen as substrate, the rate of pyruvate production exceeds the catalytic activity of pyruvate dehydrogenase, and lactate production occurs. Studies using dichloroacetate, induced acid-base changes, diet and short-term endurance training, indicate that lactate production is related to complex interactions of metabolic pathways and not related to inadequate O2 supply. As pyruvate dehydrogenase plays a central role in the integration of carbohydrate and fat metabolism, and in the entry of pyruvate into the tricarboxylic acid cycle, this enzyme plays a key role in lactate production.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10635003     DOI: 10.1007/978-1-4615-4711-2_17

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  4 in total

Review 1.  Enhancing physical performance in chronic obstructive pulmonary disease.

Authors:  M C Steiner; M D Morgan
Journal:  Thorax       Date:  2001-01       Impact factor: 9.139

2.  Switching the mode of metabolism in the yeast Saccharomyces cerevisiae.

Authors:  Karin Otterstedt; Christer Larsson; Roslyn M Bill; Anders Ståhlberg; Eckhard Boles; Stefan Hohmann; Lena Gustafsson
Journal:  EMBO Rep       Date:  2004-04-08       Impact factor: 8.807

3.  Specific Inhibition of Hepatic Lactate Dehydrogenase Reduces Oxalate Production in Mouse Models of Primary Hyperoxaluria.

Authors:  Chengjung Lai; Natalie Pursell; Jessica Gierut; Utsav Saxena; Wei Zhou; Michael Dills; Rohan Diwanji; Chaitali Dutta; Martin Koser; Naim Nazef; Rachel Storr; Boyoung Kim; Cristina Martin-Higueras; Eduardo Salido; Weimin Wang; Marc Abrams; Henryk Dudek; Bob D Brown
Journal:  Mol Ther       Date:  2018-06-15       Impact factor: 11.454

4.  Dichloroacetate-induced metabolic reprogramming improves lifespan in a Drosophila model of surviving sepsis.

Authors:  Veli Bakalov; Laura Reyes-Uribe; Rahul Deshpande; Abigail L Maloy; Steven D Shapiro; Derek C Angus; Chung-Chou H Chang; Laurence Le Moyec; Stacy Gelhaus Wendell; Ata Murat Kaynar
Journal:  PLoS One       Date:  2020-11-05       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.